Impact of Morphine Treatment With and Without Metoclopramide Coadministration on Ticagrelor-Induced Platelet Inhibition in Acute Myocardial Infarction: The Randomized MonAMI Trial.
暂无分享，去创建一个
H. Thiele | I. Eitel | S. Desch | R. Meyer‐Saraei | T. Stiermaier | T. Kurz | M. Saad | S. de Waha‐Thiele | T. Graf | J. Pöss | G. Fuernau | J. Barkhausen | H. Langer
[1] M. Marszałł,et al. Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial , 2015, European heart journal.
[2] G. Montalescot,et al. P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction , 2015, Thrombosis and Haemostasis.
[3] G. Schuler,et al. Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imaging , 2015, Clinical Research in Cardiology.
[4] I. Xanthopoulou,et al. Morphine Is Associated With a Delayed Activity of Oral Antiplatelet Agents in Patients With ST-Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention , 2014, Circulation. Cardiovascular interventions.
[5] G. Sanger,et al. The relationship between gastric motility and nausea: gastric prokinetic agents as treatments. , 2013, European journal of pharmacology.